Related Experiment Video
Updated: May 25, 2026

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses
Published on: August 31, 2014
HIV types, groups, subtypes and recombinant forms: errors in replication, selection pressure and quasispecies
1Max von Pettenkofer Institute, Ludwig Maximilian University Munich, Munich, Germany.
Abstract:
HIV-1 is a chimpanzee virus which was transmitted to humans by several zoonotic events resulting in infection with HIV-1 groups M-P, and in parallel transmission events from sooty mangabey monkey viruses leading to infections with HIV-2 groups A-H. Both viruses have circulated in the human population for about 80 years. In the infected patient, HIV mutates, and by elimination of some of the viruses by the action of the immune system individual quasispecies are formed. Along with the selection of the fittest viruses, mutation and recombination after superinfection with HIV from different groups or subtypes have resulted in the diversity of their patterns of geographic distribution. Despite the high variability observed, some essential parts of the HIV genome are highly conserved. Viral diversity is further facilitated in some parts of the HIV genome by drug selection pressure and may also be enhanced by different genetic factors, including HLA in patients from different regions of the world. Viral and human genetic factors influence pathogenesis. Viral genetic factors are proteins such as Tat, Vif and Rev. Human genetic factors associated with a better clinical outcome are proteins such as APOBEC, langerin, tetherin and chemokine receptor 5 (CCR5) and HLA B27, B57, DRB1*1303, KIR and PARD3B.
Insights
Human immunodeficiency virus (HIV) diversity arises from zoonotic origins and extensive mutation within hosts. Genetic factors in both viruses and humans significantly influence HIV pathogenesis and clinical outcomes.
Area of Science:
- Virology
- Genetics
- Immunology
Background:
- Human Immunodeficiency Virus (HIV) originated from zoonotic transmission events from chimpanzees and sooty mangabeys, leading to HIV-1 and HIV-2 infections in humans.
- Both HIV-1 and HIV-2 have circulated in human populations for approximately 80 years, undergoing significant mutation and recombination.
- Viral diversity is driven by host immune system pressure, superinfection, drug selection, and host genetic factors.
Purpose of the Study:
- To explore the origins and evolutionary dynamics of HIV diversity.
- To investigate the roles of viral and human genetic factors in HIV pathogenesis.
- To understand the impact of genetic diversity on geographic distribution and clinical outcomes.
Main Methods:
- Analysis of viral genetic sequences to identify conserved regions and patterns of mutation.
- Investigation of host genetic factors, including Human Leukocyte Antigen (HLA) and specific proteins, influencing viral evolution.
- Review of existing literature on zoonotic origins and viral evolution.
Main Results:
- HIV diversity results from zoonotic events, host immune selection, mutation, recombination, and drug pressure.
- Essential parts of the HIV genome are highly conserved despite overall variability.
- Specific viral proteins (Tat, Vif, Rev) and human genetic factors (APOBEC, CCR5, HLA variants) significantly influence pathogenesis and clinical outcomes.
Conclusions:
- HIV diversity is a complex interplay between viral evolution and host genetics.
- Understanding these genetic factors is crucial for developing effective therapeutic and preventative strategies.
- Host genetic factors like CCR5 and specific HLA types are associated with better clinical outcomes in HIV infection.
Related Concept Videos
Viral Mutations
Viral Recombination
Retrovirus Life Cycles
Retroviruses
Size and Structure of Viral Genomes
Viruses with RNA Genomes

